Pfizer Misses Sales Estimates as Revenue for Covid-19 Products Drop

Pfizer‘s third quarter financial report fell slightly short of Wall Street expectations on Tuesday morning, just weeks after the company drastically reduced its forecast for sales of its Covid-19 products